Busca un médico

Sophie J. Bakri, M.D.

  1. Ophthalmologist
  2. Chair, Ophthalmology, Minnesota
Solicite una Consulta

Publicaciones

  1. Gao AY, Whaley MG, Saraf N, Bakri SJ, Haak AJ. Survey of Dopamine Receptor D2 Antagonists as Retinal Antifibrotics. J Ocul Pharmacol Ther. 2024 Oct; 40 (8):536-542 Epub 2024 Aug 29
    View PubMed
  2. Patel S, Storey PP, Barakat MR, Hershberger V, Bridges WZ Jr, Eichenbaum DA, Lally DR, Boyer DS, Bakri SJ, Roy M, Paggiarino DA. Phase I DAVIO Trial: EYP-1901 Bioerodible, Sustained-Delivery Vorolanib Insert in Patients With Wet Age-Related Macular Degeneration. Ophthalmol Sci. 2024 Sep-Oct; 4 (5):100527 Epub 2024 Apr 09
    View PubMed
  3. Macaron MM, Al Sabbakh N, Shami MZ, Akrobetu D, Bourdakos NE, Abdulsalam FAM, Nakanishi H, Than CA, Bakri SJ. Anti-VEGF Injections vs. Panretinal Photocoagulation Laser Therapy for Proliferative Diabetic Retinopathy: A Systematic Review and Meta-Analysis. Ophthalmol Retina. 2024 Aug 14 [Epub ahead of print]
    View PubMed
  4. Shah SM, Bakri SJ. Visualization of preretinal membranes using trypan blue in patients with traction retinal detachments. Can J Ophthalmol. 2024 Aug; 59 (4):270-274 Epub 2023 June 20
    View PubMed
  5. Justin GA, Huang C, Nguyen MK, Lee J, Seddon I, Wesley TA, Bakri SJ, Peter Campbell J, Cavuoto K, Collins M, Gedde SJ, Kossler AL, Milman T, Shukla A, Sridhar J, Syed ZA, Williams JBK, Woreta FA, Patel SN, Yonekawa Y. An Analysis of Solicitations From Predatory Journals in Ophthalmology. Am J Ophthalmol. 2024 Aug; 264:216-223 Epub 2024 Mar 13
    View PubMed
  6. Bressler NM, Freund KB, Bakri SJ, Kim JE, Ferrara D, Brittain C, Pickthorn K, Lin H, Sun C, Martin J. Intraocular Pressure Outcomes After Lampalizumab Injections in Patients With Geographic Atrophy. JAMA Ophthalmol. 2024 Aug 1; 142 (8):772-776
    View PubMed
  7. Tailor PD, Dalvin LA, Chen JJ, Iezzi R, Olsen TW, Scruggs BA, Barkmeier AJ, Bakri SJ, Ryan EH, Tang PH, Parke DW 3rd, Belin PJ, Sridhar J, Xu D, Kuriyan AE, Yonekawa Y, Starr MR. A Comparative Study of Responses to Retina Questions from Either Experts, Expert-Edited Large Language Models, or Expert-Edited Large Language Models Alone. Ophthalmol Sci. 2024 Jul-Aug; 4 (4):100485 Epub 2024 Feb 06
    View PubMed
  8. Popovic MM, Balas M, Sadda SR, Sarraf D, Huang R, Bakri SJ, Berrocal A, Chang A, Gemmy Cheung CM, Garg S, Hillier RJ, Holz FG, Johnson MW, Kaiser PK, Kertes PJ, Lai TYY, Noble J, Park SS, Paulus YM, Querques G, Rachitskaya A, Ruamviboonsuk P, Saidkasimova S, Sandinha MT, Steel DH, Terasaki H, Weng CY, Williams BK Jr, Wu L, Muni RH. International Classification System for Ocular Complications of Anti-VEGF Agents in Clinical Trials. Ophthalmology. 2024 Jun 13 Epub 2024 June 13
    View PubMed
  9. Tailor PD, Xu TT, Fortes BH, Iezzi R, Olsen TW, Starr MR, Bakri SJ, Scruggs BA, Barkmeier AJ, Patel SV, Baratz KH, Bernhisel AA, Wagner LH, Tooley AA, Roddy GW, Sit AJ, Wu KY, Bothun ED, Mansukhani SA, Mohney BG, Chen JJ, Brodsky MC, Tajfirouz DA, Chodnicki KD, Smith WM, Dalvin LA. Appropriateness of Ophthalmology Recommendations From an Online Chat-Based Artificial Intelligence Model. Mayo Clin Proc Digit Health. 2024 Mar; 2(1):119-128. Epub 2024 Feb 15.
    View PubMed
  10. Zeraatkar D, Pitre T, Phillips M, Steel DH, Wykoff CC, Wong TY, Bhandari M, Chaudhary V; Retina Evidence and Trials INternational Alliance (R.E.T.I.N.A.) Study Group. The ophthalmologist's guide to evaluating the certainty of evidence using the GRADE approach Eye (Lond). 2024.
  11. Balasubramaniam SC, Dalvin LA, Bakri SJ. Prevalence of intraocular tumours detected by ultrasonography in eyes with opaque media. Can J Ophthalmol. 2024 Feb; 59(1):46-49. Epub 2022 Oct 14.
    View PubMed
  12. Lyons LJ, Kazemi A, Bakri SJ, Barkmeier AJ, Iezzi R, Olsen TW, Hodge DO, Sit AJ. The Effect of Scleral Buckle Surgery on Tonographic Outflow Facility, Positional Intraocular Pressure, and Ocular Biomechanics. Ophthalmol Glaucoma. 2024 Jan-Feb; 7(1):1-7. Epub 2023 Jul 22.
    View PubMed
  13. Bakri SJ, Amoaku WMK, Altman D, Quere S, Quilantan J, Carpenter-Conlin J, Sarda SP, Jones DL, Nielsen JS. The MOSAIC Study: A Mixed-Methods Study of the Clinical, Emotional, and Financial Burden of Geographic Atrophy Among Patients and Caregivers in the US. Clin Ophthalmol. 2024; 18:2357-2368 Epub 2024 Aug 23
    View PubMed
  14. Bakri SJ, Lynch J, Howard-Sparks M, Saint-Juste S, Saim S. Vorolanib, sunitinib, and axitinib: A comparative study of vascular endothelial growth factor receptor inhibitors and their anti-angiogenic effects. PLoS One. 2024; 19 (6):e0304782 Epub 2024 June 04
    View PubMed
  15. Willett KL, Comfere N, Bakri SJ. Scleromyxedema associated with macular edema and retinal hemorrhage. Retin Cases Brief Rep. 2023 Nov 1 Epub 2023 Nov 01
    View PubMed
  16. Chang Y, Wang L, Phillips MR, Wykoff CC, Garg SJ, Thabane L, Bhandari M, Chaudhary V; Retina Evidence and Trials INternational Alliance (R.E.T.I.N.A.) Study Group. What makes a good survey? Eye (Lond). 2023; 37(16):3299-3301.
  17. Bakri SJ, Delyfer MN, Grauslund J, Andersen S, Karcher H. Real-World Persistence and Treatment Interval in Patients with Diabetic Macular Edema Treated with Anti-Vascular Endothelial Growth Factors in the USA. Ophthalmol Ther. 2023 Oct; 12 (5):2465-2477 Epub 2023 June 22
    View PubMed
  18. Darzi AJ, Busse JW, Phillips M, Wykoff CC, Guymer RH, Thabane L, Bhandari M, Chaudhary V; Retina Evidence and Trials INternational Alliance (R.E.T.I.N.A.) Study Group. Interpreting results from randomized controlled trials: What measures to focus on in clinical practice Eye (Lond). 2023; 37(15):3055-3058.
  19. Kim K, Zeraatkar D, Pitre TS, Phillips M, Wykoff CC, Garg SJ, Guymer RH, Thabane L, Bhandari M, Chaudhary V; Retina Evidence and Trials INternational Alliance (R.E.T.I.N.A.) Study Group. Noninferiority randomised trials in ophthalmology Eye (Lond). 2023; 37(15):3059-3060.
  20. Agrón E, Domalpally A, Cukras CA, Chew EY, Keenan TDL. Critical Dependence on Area in Relationship between ARMS2/HTRA1 Genotype and Faster Geographic Atrophy Enlargement: AREDS2 Report 33 Ophthalmology. 2023; S0161-6420(23):00670-X.
  21. Gao AY, Haak AJ, Bakri SJ. In vitro laboratory models of proliferative vitreoretinopathy. Surv Ophthalmol. 2023 Sep-Oct; 68 (5):861-874 Epub 2023 May 19
    View PubMed
  22. Shah SM, Bakri SJ. SPONTANEOUS FORMATION AND RESOLUTION OF A LAMELLAR HOLE IN A PATIENT SUCCESSFULLY TREATED FOR DIABETIC MACULAR EDEMA WITH A FLUOCINOLONE ACETONIDE IMPLANT. Retin Cases Brief Rep. 2023 Sep 1; 17 (5):588-590
    View PubMed
  23. Chaudhary V; Retina Evidence and Trials INternational Alliance (R.E.T.I.N.A.) Study Group. The need for a pragmatic, individualized treat-and-extend (T&E) treatment paradigm for centre-involving diabetic macular oedema Eye (Lond). 2023; 37(12):2431-2433.
  24. Core JQ, Hua P, Daniel E, Grunwald JE, Jaffe G, Maguire MG, Ying GS, Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group. Thiazolidinedione use and retinal fluid in the comparison of age-related macular degeneration treatments trials. Br J Ophthalmol. 2023 Jul; 107(7):1000-1006. Epub 2022 Apr 15.
    View PubMed
  25. Xue K, Hua P, Maguire MG, Daniel E, Jaffe GJ, Grunwald JE, Ying GS, Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group. Prediction for 2-Year Vision Outcomes Using Early Morphologic and Functional Responses in the Comparison of Age-related Macular Degeneration Treatments Trials. Ophthalmol Retina. 2023 Jul; 7 (7):564-572 Epub 2023 Feb 19
    View PubMed
  26. Bakri SJ, Heier JS, Khanani AN, Kuppermann BD, Regillo CD, Kaiser PK. Glycoimmune Therapy as a Novel Treatment Approach for Geographic Atrophy Retinal Physician. 2023.
  27. Starr MR, Dalvin LA, AbouChehade JE, Damento GM, Garcia M, Shah SM, Hodge DO, Iezzi R, Bakri SJ. Incidence of metformin use in patients with age-related macular degeneration versus normal controls: A population-based study in Olmsted County, Minnesota. Eye (Lond). 2023 Jun; 37(9):1861-1865. Epub 2022 Sep 23.
    View PubMed
  28. Bakri SJ, Bektas M, Sharp D, Luo R, Sarda SP, Khan S. Geographic atrophy: Mechanism of disease, pathophysiology, and role of the complement system. J Manag Care Spec Pharm. 2023 May; 29 (5-a Suppl):S2-S11
    View PubMed
  29. Bahr TA, Bakri SJ. Update on the Management of Diabetic Retinopathy: Anti-VEGF Agents for the Prevention of Complications and Progression of Nonproliferative and Proliferative Retinopathy. Life (Basel). 2023 Apr 27; 13 (5)
    View PubMed
  30. Chaudhary V, Sarohia GS, Phillips MR, Zeraatkar D, Xie J, Nanji K, Mustafa RA, Kaiser PK, Loewenstein A, Garg SJ, Bakri SJ, Holz FG, Sivaprasad S, Bhandari M, Steel DH, Wykoff CC. Role of Positioning after Full-Thickness Macular Hole Surgery: A Systematic Review and Meta-Analysis. Ophthalmol Retina. 2023 Jan; 7 (1):33-43 Epub 2022 July 01
    View PubMed
  31. Rosenberg D, Deonarain DM, Gould J, Sothivannan A, Phillips MR, Sarohia GS, Sivaprasad S, Wykoff CC, Cheung CMG, Sarraf D, Bakri SJ, Chaudhary V. Efficacy, safety, and treatment burden of treat-and-extend versus alternative anti-VEGF regimens for nAMD: a systematic review and meta-analysis. Eye (Lond). 2023 Jan; 37 (1):6-16 Epub 2022 Apr 08
    View PubMed
  32. Fortes BH, Astafurov KV, Hodge DO, Smith WM, Barkmeier AJ, Olsen TW, Iezzi R, Bakri SJ. EFFECT OF PHYSICIAN FACE MASK USE ON POSTINJECTION ENDOPHTHALMITIS. Retina. 2022 Nov 1; 42 (11):2120-2127
    View PubMed
  33. Shah SM, Boopathiraj N, Starr MR, Dalvin LA, AbouChehade J, Damento G, Garcia MD, Hodge DO, Bakri SJ, Sit AJ, Iezzi R. Risk, Prevalence, and Progression of Glaucoma in Eyes With Age-Related Macular Degeneration Treated With Intravitreal Anti-Vascular Endothelial Growth Factor Injections. Am J Ophthalmol. 2022 Nov; 243:98-108. Epub 2022 Aug 03.
    View PubMed
  34. Bakri SJ, Karcher H, Andersen S, Souied EH. Anti-Vascular Endothelial Growth Factor Treatment Discontinuation and Interval in Neovascular Age-Related Macular Degeneration in the United States. Am J Ophthalmol. 2022 Oct; 242:189-196 Epub 2022 June 21
    View PubMed
  35. Khanani AM, Regillo CR, Wykoff CC, Moshfeghi AM, Weng CY, Bakri SJ, Kaiser PK. Sustained-Release of Tyrosine Kinase Inhibitors for the Treatment of nAMD Retinap Physician. 2022.
  36. Chaudhary V. Treat & extend in neovascular age-related macular degeneration: how we got here and where do we go next? Eye (London). 2022.
  37. Bui YT, Starr MR, Kung FF, Mejia CA, Bakri SJ. Long-Term Visual Outcomes in Exudative Age-Related Macular Degeneration Patients With Unanticipated Gaps in Therapy. Ophthalmic Surg Lasers Imaging Retina. 2022 Sep; 53 (9):481-489 Epub 2022 Sept 01
    View PubMed
  38. Agrón E, Mares J, Chew EY, Keenan TDL. Adherence to a Mediterranean Diet and Geographic Atrophy Enlargement Rate: Age-Related Eye Disease Study 2 Report 29 Ophthalmol Retina. 2022; 6(9):762-770.
  39. Gao AY, Link PA, Bakri SJ, Haak AJ. Dopamine receptor signaling regulates fibrotic activation of retinal pigmented epithelial cells. Am J Physiol Cell Physiol. 2022 Jul 1; 323 (1):C116-C124 Epub 2022 May 11
    View PubMed
  40. Chew EY, Clemons TE, Agrón E, Domalpally A, Keenan TDL, Vitale S, Weber C, Smith DC, Christen W, AREDS2 Research Group. Long-term Outcomes of Adding Lutein/Zeaxanthin and ?-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28. JAMA Ophthalmol. 2022 Jul 01; 140(7):692-698.
    View PubMed
  41. Le JT, Agrón E, Keenan TDL, Clemons TE, Brenowitz WD, Yaffe K, Chew EY. Assessing bidirectional associations between cognitive impairment and late age-related macular degeneration in the Age-Related Eye Disease Study 2 Alzheimers Dement. 2022; 18(7):1296-1305.
  42. Dalvin LA, Olsen TW, Bakri SJ, McCullough K, Tefferi A, Al-Kali A. Busulfan Treatment for Myeloproliferative Disease may Reduce Injection Burden in Vascular Endothelial Growth Factor-Driven Retinopathy. Am J Ophthalmol Case Rep. 2022 Jun; 26:101554 Epub 2022 Apr 21
    View PubMed
  43. Parpia S, Morris TP, Phillips MR, Wykoff CC, Steel DH, Thabane L, Bhandari M, Chaudhary V. Sensitivity analysis in clinical trials: three criteria for a valid sensitivity analysis Eye (London). 2022.
  44. Nanji K, Sarohia GS, Kennedy K, Ceyhan T, McKechnie T, Phillips M, Devji T, Thabane L, Kaiser P, Sarraf D, Garg SJ, Sivaprasad S, Wykoff CC, Bakri SJ, Sheidow T, Bhandari M, Chaudhary V. The 12- and 24-Month Effects of Intravitreal Ranibizumab, Aflibercept, and Bevacizumab on Intraocular Pressure: A Network Meta-Analysis. Ophthalmology. 2022 May; 129 (5):498-508 Epub 2021 Dec 04
    View PubMed
  45. 173. Y, Phillips MR, Guymer RH, Thabane L, Bhandari M, Chaudhary V. The 5?min meta-analysis: understanding how to read and interpret a forest plot Eye (London). 2022; 36(4):673-675.
  46. Bakri SJ, Malhotra M, Stoilov I. Course of Diabetic Retinopathy in Untreated Fellow Eyes in RIDE and RISE: A Post Hoc Analysis Ophthalmic Surg Lasers Imaging Retina. 2022; 53(4):202-207.
  47. Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA. Baseline Characteristics and Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion: Study of Comparative Treatments for Retinal Vein Occlusion 2 JAMA Ophthalmol.. 2022.
  48. Patel M, Salazar H, Watane A, Yannuzzi N, Bounds G, Reddy A, Bakri SJ, Sridhar J. Representation of Women in Ophthalmology Receiving Private Industry Funding 2015-2018. Am J Ophthalmol. 2022 Mar; 235:56-62 Epub 2021 Sept 10
    View PubMed
  49. Thabane A, Phillips MR, Wong TY, Thabane L, Bhandari M, Chaudhary V, Retina Evidence Trials InterNational Alliance. The clinician's guide to randomized trials: interpretation Eye (London). 2022; 36(3):481-482.
  50. 181. MR, Steel DH, Wykoff CC, Busse JW, Bannuru RR, Thabane L, Bhandari M, Chaudhary V. A clinician's guide to network meta-analysis Eye (London). 2022.
  51. 179. F, Skorzewski P, Phillips MR, Garg SJ, Sarraf D, Thabane L, Bhandari M, Chaudhary V. When to believe a subgroup analysis: revisiting the 11 criteria Eye (London). 2022.
  52. Bzovsky S, Phillips MR, Guymer RH, Wykoff CC, Thabane L, Bhandari M, Chaudhary V. 180. The clinician's guide to interpreting a regression analysis Eye (London). 2022.
  53. 178. AJ, Busse JW, Phillips MR, Singh RP, Holz FG, Thabane L, Bhandari M, Chaudhary V. Guidelines for patient management: considerations before adoption into practice Eye (London). 2022.
  54. Phillips MR, Wykoff CC, Thabane L, Bhandari M, Chaudhary V, Retina Evidence Trials InterNational Alliance (R.E.T.I.N.A.) Study Group. Correction to: The clinician's guide to p values, confidence intervals, and magnitude of effects. Eye (Lond). 2022 Jan 19 [Epub ahead of print]
    View PubMed
  55. Phillips MR, Kaiser P, Thabane L, Bhandari M, Chaudhary V, Retina Evidence Trials InterNational Alliance (R.E.T.I.N.A.) Study Group. Correction to: Risk of bias: why measure it, and how? Eye (Lond). 2022 Jan 19 [Epub ahead of print]
    View PubMed
  56. Rosenberg DM, Ghayur HS, Deonarain DM, Sarohia GS, Phillips MR, Garg S, Bakri SJ, Wykoff CC, Chaudhary V. Supplemental Scleral Buckle for the Management of Rhegmatogenous Retinal Detachment by Pars Plana Vitrectomy: A Meta-Analysis of Randomized Controlled Trials. Ophthalmologica 2022; 245 (2):101-110 Epub 2021 Nov 03
    View PubMed
  57. Shah SM, Boopathiraj N, Starr MR, Dalvin LA, AbouChehade J, Damento G, Garcia MD, Hodge DO, Bakri SJ, Sit AJ, Iezzi R. Risk, prevalence, and progression of glaucoma in eyes with age-related macular degeneration treated with intravitreal anti–vascular endothelial growth factor injections. American Journal of Ophthalmology. 2022; 243:98-108
  58. Aref AA, Scott IU, VanVeldhuisen PC, King J, Ip MS, Blodi BA, Oden NL, Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) investigator Group. Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial JAMA Ophthalmology. 2021; 139(12):1285-1291.
  59. Bakri SJ, Shah SM. Predatory Conferences: Calling for Vigilance From Ophthalmologists and Vision Scientists. Am J Ophthalmol. 2021 Oct; 230:178-180 Epub 2021 Apr 06
    View PubMed
  60. Starr MR, Softing Hataye AL, Bakri SJ. ASYMPTOMATIC MULTIFOCAL PARACENTRAL ACUTE MIDDLE MACULOPATHY ASSOCIATED WITH JUVENILE DERMATOMYOSITIS: OPTICAL COHERENCE ANGIOGRAPHY FINDINGS. Retin Cases Brief Rep. 2021 Sep 1; 15 (5):500-503
    View PubMed
  61. Starr MR, Mahr MA, Smith WM, Iezzi R, Barkmeier AJ, Bakri SJ. Outcomes of Patients With Active Diabetic Macular Edema at the Time of Cataract Surgery Managed With Intravitreal Anti-Vascular Endothelial Growth Factor Injections. Am J Ophthalmol. 2021 Sep; 229:194-199. Epub 2021 Apr 20.
    View PubMed
  62. Grosinger AJ, Nicholson BP, Shah SM, Pulido JS, Barkmeier AJ, Iezzi R, Bakri SJ. Time to Unplanned Return to the Operating Room and Associated Risk Factors in Patients With Surgical Retinal Detachment Repair. Am J Ophthalmol. 2021 Sep; 229:18-25. Epub 2021 Feb 21.
    View PubMed
  63. Shah SM, Schimmenti LA, Marmorstein AD, Bakri SJ. ADULT-ONSET VITELLIFORM MACULAR DYSTROPHY SECONDARY TO A NOVEL IMPG2 GENE VARIANT. Retin Cases Brief Rep. 2021 Jul 1; 15 (4):356-358
    View PubMed
  64. Starr MR, Bakri SJ. The Use of Tutoplast as an Adjunct in Scleral Buckle Procedure in Patients with Extremely Thin Sclera. J Ophthalmic Vis Res. 2021 Jul-Sep; 16 (3):521-523 Epub 2021 July 29
    View PubMed
  65. Fortes BH, Dalvin LA, Bakri SJ. Multimodal imaging of sclerochoroidal calcification associated with choroidal neovascular membrane. Can J Ophthalmol 2021 Jun; 56 (3):e98-e101 Epub 2020 Nov 26
    View PubMed
  66. Astafurov KV, Bakri SJ, Barkmeier AJ. Ocular Toxicity Associated With Pentosan Polysulfate Sodium. Mayo Clin Proc 2021 Jun; 96 (6):1682-1684
    View PubMed
  67. Finn AP, Pistilli M, Tai V, Daniel E, Ying GS, Maguire MG, Grunwald JE, Martin DF, Jaffe GH, Toth CA, CATT Research Group. Localized Optical Coherence Tomography Precursors of Macular Atrophy and Fibrotic Scar in the Comparison of Age-Related Macular Degeneration Treatments Trials. Am J Ophthalmol.. 2021; 223:338-347.
  68. Hwang CK, Agrón E, Domalpally A, Cukras CA, Wong WT, Chew EY, Keenan TDL. Progression of Geographic Atrophy with Subsequent Exudative Neovascular Disease in Age-Related Macular Degeneration: AREDS2 Report 24 Ophthalmol Retina. 2021; 5(2):108-117.
  69. Azad AD, Zhou M, Afshar AR, Bakri SJ, Pershing S. Systemic Corticosteroid Use after Central Serous Chorioretinopathy Diagnosis. Ophthalmology. 2021 Jan; 128 (1):121-129 Epub 2020 June 30
    View PubMed
  70. Bakri SJ, Berrocal AM, Berrocal MH, Chan RVC, Schaal S. The next generation of leaders in retina: New chairs in retina talk about their journeys to leadership, including hurdles, lessons learned, and future aspirations Retina Today. 2021; 2021:28-32
  71. Bakri SJ, Shah SM. Predatory Publishing in Ophthalmology: A Call for Awareness and Action. Am J Ophthalmol 2021 Jan; 221:207-210 Epub 2020 Aug 13
    View PubMed
  72. Kolomeyer AM, Smith E, Daniel E, Ying GS, Pan W, Pistilli M, Grunwald J, Maguire MG, Kim BJ, CATT Research Group. Beta-Peripapillary Atrophy and Geographic Atrophy in The Comparison of Age-related Macular Degeneration Treatments Trials. Retina. 2021; 41(1):125-134.
  73. Delu S, Peiying V, Josha D, Juan G, Ebenezer D, Maureen M, Daniel M, Gui-Shuang Y, CATT. Systemic Medication use and the Incidence and Growth of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT). Retina. 2020.
  74. Shah SM, Khanna CL, Yamanuha J, Bakri SJ. "Glaucomatous fields" after monthly intravitreal injections: Normal tension glaucoma or a mimicker? Am J Ophthalmol Case Rep. 2020 Dec; 20:100904 Epub 2020 Aug 25
    View PubMed
  75. Shah SM, Barkmeier AJ, Bakri SJ. Recurrent panuveitis after initial treatment of endophthalmitis secondary to intravitreal anti-vascular endothelial growth factor. Can J Ophthalmol 2020 Dec; 55 (6):e195-e197 Epub 2020 Aug 20
    View PubMed
  76. Kung FF, Starr MR, Bui YT, Mejia CA, Bakri SJ. Long-Term Follow-up of Patients with Exudative Age-Related Macular Degeneration Treated with Intravitreal Anti-Vascular Endothelial Growth Factor Injections. Ophthalmol Retina. 2020 Nov; 4(11):1047-1053. Epub 2020 May 19.
    View PubMed
  77. Starr MR, Kung FF, Mejia CA, Bui YT, Bakri SJ. TEN-YEAR FOLLOW-UP OF PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS. Retina. 2020 Sep; 40(9):1665-1672.
    View PubMed
  78. Roddy GW, Rosa RH, Viker KB, Holman BH, Hann CR, Krishnan A, Gores GJ, Bakri SJ, Fautsch MP. Diet Mimicking "Fast Food" Causes Structural Changes to the Retina Relevant to Age-Related Macular Degeneration. Curr Eye Res. 2020 Jun; 45 (6):726-732 Epub 2019 Dec 02
    View PubMed
  79. Starr MR, Mahr MA, Iezzi R, Barkmeier AJ, Bakri SJ. Visual and Anatomic Outcomes following Cataract Surgery in Patients with Pre-operative Macular Edema Due to Retinal Vein Occlusions Managed with Intravitreal anti-VEGF. Semin Ophthalmol. 2020 May 18; 35(4):205-209. Epub 2020 Jul 28.
    View PubMed
  80. Shah SM, Starr MR, Dalvin LA, Comfere NI, AbouChehade JE, Hodge DO, Iezzi R, Bakri SJ. INCREASED INCIDENCE OF CUTANEOUS KERATINOCYTIC AND MELANOCYTIC MALIGNANCIES IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION. Retina. 2020 May; 40 (5):857-865
    View PubMed
  81. Starr MR, Iezzi R, Bakri SJ. Twenty-Year Incidence of Macular Telangiectasia Type 2 and Associated Systemic Comorbidities in Olmsted County, Minnesota. Ophthalmic Surg Lasers Imaging Retina. 2020 May 01; 51(5):S35-S42.
    View PubMed
  82. Shah SM, Bakri SJ. Adherence of Intravitreal Silicone Oil Bubbles to a Silicone Intraocular Lens. Ophthalmic Surg Lasers Imaging Retina. 2020 May 1; 51 (5):307
    View PubMed
  83. Daniel E, Maguire MG, Grunwald JE, Toth CA, Jaffe GJ, Martin DF, Ying GS, CATT. Incidence and Progression of Nongeographic Atrophy in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Clinical Trial JAMA Ophthalmology. 2020; 138(5):510-518.
  84. Martin DF, Maguire MG, Fine SL, Ying GS, Jaffe GJ, Grunwald JE, Toth C, Redford M, Ferris FL 3rd. Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: Two-Year Results Ophthalmology. 2020; 127(4S):S135-S145.
  85. Scoles D, Ying GS, Pan W, Hua P, Grunwald JE, Daniel E, Jaffe GJ, Toth CA, Martin DF, Maguire MG, CATT Research Group . Characteristics of Eyes With Good Visual Acuity at 5 Years After Initiation of Treatment for Age-Related Macular Degeneration but Not Receiving Treatment From Years 3 to 5: Post Hoc Analysis of the CATT Randomized Clinical Trial JAMA Ophthalmol. 2020.
    View PubMed
  86. Keenan TD, Vitale S, Agrón E, Domalpally A, Antoszyk AN, Elman MJ, Clemons TE, Chew EY, AREDS 2 Research Group . Visual Acuity Outcomes after Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 19 Ophthalmol Retina. 2020; 4(1):3-12..
    View PubMed
  87. Starr MR, Iezzi R, Bakri SJ. Twenty-year incidence of macular telangiectasia type 2 and associated systemic comorbidities in Olmsted County, Minnesota Ophthalmic Surgery Lasers and Imaging Retina. 2020; 51 (5):S35-42
  88. Zhou M, Bakri SJ, Pershing S. Risk factors for incident central serous retinopathy: case-control analysis of a US national managed care population. Br J Ophthalmol. 2019 Dec; 103 (12):1784-1788 Epub 2019 Mar 14
    View PubMed
  89. Starr MR, Barkmeier AJ, Engman SJ, Kitzmann A, Bakri SJ. Telemedicine in the Management of Exudative Age-Related Macular Degeneration within an Integrated health care System. Am J Ophthalmol. 2019 Dec; 208:206-210. Epub 2019 Mar 21.
    View PubMed
  90. Keenan TD, Wiley HE, Agrón E, Aronow ME, Christen WG, Clemons TE, Chew EY, AREDS2 Research Group . The Association of Aspirin Use with Age-Related Macular Degeneration Progression in the Age-Related Eye Disease Studies: Age-Related Eye Disease Study 2 Report No. 20 Ophthalmology. 2019; 126(12):1647-1656..
    View PubMed
  91. Christakis PG, Agrón E, Klein ML, Clemons TE, Campbell JP, Ferris FL, Chew EY, Keenan TD, AREDS. Incidence of Macular Atrophy after Untreated Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study Report 40 Ophthalmology. 2019.
  92. Pauleikhoff D, Bonelli R, Dubis AM, Gunnemann F, Rothaus K, Charbel Issa P, Heeren TF, Peto T, Clemons TE, Chew EY, Bird AC, Sallo FB. Progression characteristics of ellipsoid zone loss in macular telangiectasia type 2 Acta Ophthalmol. 2019; 97(7):e998-e1005.. Epub 2019 Apr 19.
    View PubMed
  93. Van F, Chiu CY, Agrón E, Clemons TE, Ratnapriya R, Swaroop A, Klein ML, Fan R, Chew EY, AREDS2 Research Group . No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or ß-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: AREDS2 Report No. 18 Ophthalmology. 2019.
    View PubMed
  94. Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA, Chan CK. Month 24 Outcomes After Treatment Initiation With Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion: SCORE2 Report 10: A Secondary Analysis of the SCORE2 Randomized Clinical Trial JAMA Ophthalmol. 2019.
  95. Bavinger JC, Ying GS, Daniel E, Grunwald JE, Maguire MG. Association Between Cilioretinal Arteries and Advanced Age-Related Macular Degeneration: Secondary Analysis of the Comparison of Age-Related Macular Degeneration Treatment Trials (CATT) JAMA Ophthalmol. 2019; 137(11):1306-11.
  96. Peterson JS, Rockwell K Jr, Scott IU, Ip MS, VanVeldhuisen PC, Blodi BA, SCORE2 Investigator Group . Long-Term Physical Stability, Sterility, And Anti-Vegf Bioactivity Of Repackaged Bevacizumab In 2-Ml Glass Vials Retina. 2019.
    View PubMed
  97. Dalvin LA, Starr MR, AbouChehade JE, Damento GM, Garcia M, Shah SM, Hodge DO, Meissner I, Bakri SJ, Iezzi R. Association of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy With Risk of Stroke, Myocardial Infarction, and Death in Patients With Exudative Age-Related Macular Degeneration. JAMA Ophthalmol. 2019 May 01; 137(5):483-490.
    View PubMed
  98. Starr MR, Dalvin LA, AbouChehade JE, Damento GM, Garcia MD, Shah SM, Hodge DO, Meissner I, Iezzi R, Bakri SJ. Classification of Strokes in Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor. Ophthalmic Surg Lasers Imaging Retina. 2019 May 01; 50(5):e140-e157.
    View PubMed
  99. Bakri SJ, Wolfe JD, Regillo CD, Flynn HW, Wykoff CC. Evidence-Based Guidelines for Management of Diabetic Macular Edema Journal of Vitreoretinal Diseases. 2019; 3(3):145-152.
  100. Daniel E, Ying GS, Kim BJ, Toth CA, Ferris F 3rd, Martin DF, Grunwald JE, Jaffe GJ, Dunaief JL, Pan W, Maguire MG, CATT. Five-Year Follow-up of Nonfibrotic Scars in the Comparison of Age-Related Macular Degeneration Treatments Trials Ophthalmology. 2019; 126(5):743-751..
    View PubMed
  101. Toth CA, Tai V, Pistilli M, Chiu SJ, Winter KP, Daniel E, Grunwald JE, Jaffe GJ, Martin DF, Ying GS, Farsiu S, Maguire MG, CATT. Distribution of OCT Features within Areas of Macular Atrophy or Scar after 2 Years of Anti-VEGF Treatment for Neovascular AMD in CATT Ophthalmol Retina. 2019; 3(4):316-325. Epub 2018 Dec 03.
    View PubMed
  102. Shah SM, Bakri SJ. Association Between Modifiable Cardiovascular Risk Factors and Age-related Macular Degeneration Ophthalmology Management. 2019.
  103. Ip MS, Oden NL, Scott IU, VanVeldhuisen PC, Blodi BA, Ghuman T, Baker CW, SCORE2 Investigator Group. Month 12 Outcomes After Treatment Change at Month 6 Among Poor Responders to Aflibercept or Bevacizumab in Eyes With Macular Edema Secondary to Central or Hemiretinal Vein Occlusion: A Secondary Analysis of the SCORE2 Study JAMA Ophthalmol. 2019; 137(3):281-287..
    View PubMed
  104. Jaffe GJ, Ying GS, Toth CA, Daniel E, Grunwald JE, Martin DF, Maguire MG, CATT Research Group . Macular Morphology and Visual Acuity in Year Five of the Comparison of Age-related Macular Degeneration Treatments Trials Ophthalmology. 2019; 126(2):252-260.
    View PubMed
  105. Yu JJ, Agrón E, Clemons TE, Domalpally A, van Asten F, Keenan TD, Cukras C, Chew EY, Age-Related Eye Disease Study 2 Research Group. Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17. Ophthalmology. 2019 Feb; 126(2):261-273. Epub 2018 Aug 22.
    View PubMed
  106. Mansukhani SA, Barkmeier AJ, Bakri SJ, Iezzi R, Pulido JS, Khanna CL, Bennett JR, Hodge DO, Sit AJ. The Risk of Primary Open-Angle Glaucoma Following Vitreoretinal Surgery-A Population-based Study. Am J Ophthalmol 2019 Jan 22 [Epub ahead of print]
    View PubMed
  107. Bakri SJ, Thorne JE, Ho AC, Ehlers JP, Schoenberger SD, Yeh S, Kim SJ. Safety and Efficacy of Anti-Vascular Endothelial Growth Factor Therapies for Neovascular Age-Related Macular Degeneration: A Report by the American Academy of Ophthalmology. Ophthalmology. 2019 Jan; 126 (1):55-63 Epub 2018 Aug 02
    View PubMed
  108. Diaconita V, Rihani H, Mares V, Nehemy MB, Bakri SJ, Pulido JS. The use of anterior segment optical coherence tomography (ASOCT) in demonstrating recurrence of vitreoretinal lymphoma (VRL) in the anterior vitreous. Int J Retina Vitreous. 2019; 5:19 Epub 2019 Aug 20
    View PubMed
  109. Domalpally A, Danis RP, Trane R, Blodi BA, Clemons TE, Chew EY, AREDS2 Research Group . Atrophy in Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 15 Ophthalmol Retina. 2018; 2(10):1021-1027.
    View PubMed
  110. Mansukhani SA, Barkmeier AJ, Bakri SJ, Iezzi R, Pulido JS, Khanna CL, Bennett JR, Hodge DO, Sit AJ. The Risk of Primary Open-Angle Glaucoma Following Vitreoretinal Surgery-A Population-based Study. Am J Ophthalmol. 2018 Sep; 193:143-155 Epub 2018 June 27
    View PubMed
  111. Starr MR, Mahr MA, Barkmeier AJ, Iezzi R, Smith WM, Bakri SJ. Outcomes of Cataract Surgery in Patients With Exudative Age-related Macular Degeneration and Macular Fluid. Am J Ophthalmol. 2018 Aug; 192:91-97. Epub 2018 May 23.
    View PubMed
  112. Sathiamoorthi S, Ruddy KJ, Bakri SJ. Association of Uveitis and Macular Edema With Anastrozole Therapy. JAMA Ophthalmol. 2018 Jul 1; 136 (7):837-839
    View PubMed
  113. Daniel E, Pan W, Ying GS, Kim BJ, Grunwald JE, Ferris FL 3rd, Jaffe GJ, Toth CA, Martin DF, Fine SL, Maguire MG, CATT Research Group. Development and Course of Scars in the Comparison of Age-Related Macular Degeneration Treatments Trials Ophthalmology. 2018; 125(7):1037-1046..
    View PubMed
  114. Chu S, Nesper PL, Soetikno BT, Bakri SJ, Fawzi AA. Projection-Resolved OCT Angiography of Microvascular Changes in Paracentral Acute Middle Maculopathy and Acute Macular Neuroretinopathy. Invest Ophthalmol Vis Sci. 2018 Jun 1; 59 (7):2913-2922
    View PubMed
  115. Lin LY, Zhou Q, Hagstrom S, Maguire MG, Daniel E, Grunwald JE, Martin DF, Ying GS, CATT. Association of Single-Nucleotide Polymorphisms in Age-Related Macular Degeneration With Pseudodrusen: Secondary Analysis of Data From the Comparison of AMD Treatments Trials JAMA Ophthalmol. 2018.
  116. Ying GS, Maguire MG, Pan W, Grunwald JE, Daniel E, Jaffe GJ, Toth CA, Hagstrom SA, Martin DF. Baseline Predictors for Five-Year Visual Acuity Outcomes in the Comparison of AMD Treatment Trials Ophthalmol Retina. 2018; 2(6):525-530.
  117. Toth CA, Tai V, Chiu SJ, Winter K, Sevilla MB, Daniel E, Grunwald JE, Jaffe GJ, Martin DF, Ying GS, Pistilli M, Farsiu S, Maguire MG, CATT. Linking OCT, Angiographic, and Photographic Lesion Components in Neovascular Age-Related Macular Degeneration Ophthalmol Retina. 2018.
  118. AREDS2, Papudesu C, Clemons TE, Agrón E, Chew EY. Association of Mortality with Ocular Diseases and Visual Impairment in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 13 Ophthalmology. 2018.
  119. Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, Altaweel M, Berinstein DM, SCORE2. Comparison of Monthly vs Treat-and-Extend Regimens for Individuals With Macular Edema Who Respond Well to Anti-Vascular Endothelial Growth Factor Medications: Secondary Outcomes From the SCORE2 Randomized Clinical Trial JAMA Ophthalmol. 2018.
  120. Van F, Simmons M, Singhal A, Keenan TD, Ratnapriya R, Agrón E, Clemons TE, Swaroop A, Lu Z, Chew EY, AREDS2. A Deep Phenotype Association Study Reveals Specific Phenotype Associations with Genetic Variants in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 (AREDS2) Report No. 14. Ophthalmology. 2018.
  121. Atchison EA, Bakri SJ. Intraocular Pressure after Intravitreal Triesence Injection. Semin Ophthalmol. 2018; 33 (3):308-312 Epub 2016 Dec 09
    View PubMed
  122. Alniemi ST, Amin SR, Sculley L, Bakri SJ. Ultrasound Biomicroscopy in Pseudophakic Patients with Unexplained Recurrent Hyphema or Vitreous Hemorrhage. Semin Ophthalmol. 2018; 33 (2):260-264 Epub 2016 Dec 14
    View PubMed
  123. Starr MR, Norby SM, Scott JP, Bakri SJ. Acute retinal vein occlusion and cystic fibrosis. Int J Retina Vitreous. 2018; 4:26 Epub 2018 July 18
    View PubMed
  124. Nicholson BP, Ali Idris AM, Bakri SJ. Central Serous Chorioretinopathy: Clinical Characteristics Associated with Visual Outcomes. Semin Ophthalmol. 2018; 33 (6):804-807 Epub 2018 Aug 01
    View PubMed
  125. Nicholson BP, Atchison E, Idris AA, Bakri SJ. Central serous chorioretinopathy and glucocorticoids: an update on evidence for association. Surv Ophthalmol. 2018 Jan - Feb; 63 (1):1-8 Epub 2017 June 30
    View PubMed
  126. Leung I, Sallo FB, Bonelli R, Clemons TE, Pauleikhoff D, Chew EY, Bird AC, Peto T, MacTel. Characteristics of pigmented lesions in type 2 idiopathic macular telangiectasia Retina. 2018.
  127. Wolf-Schnurrbusch, Leung I, Sallo FB, Clemons TE, Chew EY, Bird AC, Peto T, MacTel. Potential Effects of Hormone Therapy in Type 2 Idiopathic Macular Telangiectasia Ophthalmic Res. 2018.
  128. Sallo FB, Leung I, Zeimer M, Clemons TE, Dubis AM, Fruttiger M, Pauleikhoff D, Chew EY, Egan C, Peto T, Bird AC, MacTel Study Group . Abnormal Retinal Reflectivity To Short-Wavelength Light In Type 2 Idiopathic Macular Telangiectasia Retina. 2018.
    View PubMed
  129. Scott IU, Figueroa MJ, Oden NL, Ip MS, Blodi BA, VanVeldhuisen PC, SCORE2. SCORE2 Report 5: Vision-Related Function in Patients With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion Am J Ophthalmol. 2017.
  130. Ehlers JP, Kim SJ, Yeh S, Thorne JE, Mruthyunjaya P, Schoenberger SD, Bakri SJ. Therapies for Macular Edema Associated with Branch Retinal Vein Occlusion: A Report by the American Academy of Ophthalmology. Ophthalmology. 2017 Sep; 124 (9):1412-1423 Epub 2017 May 24
    View PubMed
  131. Zhou Q, Daniel E, Grunwald JE, Maguire MG, Gewaily DY, Martin DF, Ying GS, CATT. Association between pseudodrusen and delayed patchy choroidal filling in the comparison of age-related macular degeneration treatments trials Acta Ophthalmol. 2017.
  132. Lim JI, Glassman AR, Aiello LP, Chakravarthy U, Flaxel CJ, Singerman LJ, Spaide RF, Roth DB, Macula Society Ocriplasmin for Vitreomacular Traction Study Group. Macula Society Collaborative Retrospective Study of Ocriplasmin for Symptomatic Vitreomacular Adhesion. Ophthalmol Retina. 2017 Sep - Oct; 1 (5):413-420 Epub 2017 Apr 25
    View PubMed
  133. Atchison EA, Omar AF, Iezzi R, Barkmeier AJ, Bakri SJ. OUTCOMES OF AN INTRAVITREAL INJECTION CLINIC. Retina. 2017 Jul; 37(7):1371-1376.
    View PubMed
  134. Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, King J, Antoszyk AN, Peters MA, Tolentino M, SCORE2. Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4 JAMA Ophthalmol. 2017.
  135. Mukherjee D, Lad EM, Vann RR, Jaffe SJ, Clemons TE, Friedlander M, Chew EY, Jaffe GJ, Farsiu S, MacTel. Correlation Between Macular Integrity Assessment and Optical Coherence Tomography Imaging of Ellipsoid Zone in Macular Telangiectasia Type 2 Invest Ophthalmol Vis Sci. 2017.
  136. Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, Awh CC, Kunimoto DY, Marcus DM, Wroblewski JJ, King J, SCORE2. Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion: The SCORE2 Randomized Clinical Trial JAMA. 2017.
  137. Schoenberger SD, Kim SJ, Thorne JE, Mruthyunjaya P, Yeh S, Bakri SJ, Ehlers JP. Diagnosis and Treatment of Acute Retinal Necrosis: A Report by the American Academy of Ophthalmology. Ophthalmology. 2017 Mar; 124 (3):382-392 Epub 2017 Jan 13
    View PubMed
  138. Reddy AK, Bounds GW, Bakri SJ, Gordon LK, Smith JR, Haller JA, Berrocal AM, Thorne JE. Differences in Clinical Activity and Medicare Payments for Female vs Male Ophthalmologists. JAMA Ophthalmol. 2017 Mar 1; 135 (3):205-213
    View PubMed
  139. Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, Figueroa M, Dugel PU, SCORE2. SCORE2 Report 2: Study Design and Baseline Characteristics Ophthalmology. 2017.
  140. Grunwald JE, Pistilli M, Daniel E, Ying GS, Pan W, Jaffe GJ, Toth CA, Hagstrom SA, Maguire MG, Martin DF, CATT. Incidence and Growth of Geographic Atrophy during 5 Years of Comparison of Age-Related Macular Degeneration Treatments Trials Ophthalmology. 2017.
  141. Daniel E, Grunwald JE, Kim BJ, Maguire MG, Jaffe GJ, Toth CA, Ferris FL 3rd, Martin DF, Shaffer J, Ying GS, CATT. Visual and Morphologic Outcomes in Eyes with Hard Exudate in the Comparison of Age-Related Macular Degeneration Treatments Trials Ophthalmol Retina. 2017.
  142. Bakri SJ, Omar AF, Iezzi R, Kapoor K. Reply. Retina 2016 Nov; 36 (11):e111-e112
    View PubMed
  143. Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, Figueroa M, SCORE2. SCORE2 Report 1: Techniques to Optimize Recruitment in Phase III Clinical Trials of Patients With Central Retinal Vein Occlusion Am J Ophthalmol. 2016.
  144. CATT, Maguire MG, Martin DF, Ying GS, Jaffe GJ, Daniel E, Grunwald JE, Toth CA, Ferris FL 3rd, Fine SL. Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials Ophthalmology. 2016.
  145. Zhou Q, Daniel E, Maguire MG, Grunwald JE, Martin ER, Martin DF, Ying GS, TT. Pseudodrusen and Incidence of Late Age-Related Macular Degeneration in Fellow Eyes in the Comparison of Age-Related Macular Degeneration Treatments Trials Ophthalmology. 2016.
  146. Alniemi ST, Bakri SJ, Cherfan C, Mohney BG. Successfully managed endophthalmitis following strabismus surgery. J AAPOS. 2016 Jun; 20 (3):263-6
    View PubMed
  147. Reddy AK, Bounds GW, Bakri SJ, Gordon LK, Smith JR, Haller JA, Thorne JE. Representation of Women With Industry Ties in Ophthalmology. JAMA Ophthalmol. 2016 Jun 1; 134 (6):636-43
    View PubMed
  148. Maguire MG, Ying GS, Jaffe GJ, Toth CA, Daniel E, Grunwald J, Martin DF, Hagstrom SA, CATT. Single-Nucleotide Polymorphisms Associated With Age-Related Macular Degeneration and Lesion Phenotypes in the Comparison of Age-Related Macular Degeneration Treatments Trials Ophthalmology. 2016.
  149. Dedania VS, Bakri SJ. Systemic safety of intravitreal anti-vascular endothelial growth factor agents in age-related macular degeneration. Curr Opin Ophthalmol. 2016 May; 27 (3):224-43
    View PubMed
  150. Shah N, Maguire MG, Martin DF, Shaffer J, Ying GS, Grunwald JE, Toth CA, Jaffe GJ, Daniel E, Comparison of Age-related Macular Degeneration Treatments Trials Research Group. Angiographic Cystoid Macular Edema and Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials. Ophthalmology. 2016 Apr; 123(4):858-64. Epub 2016 Jan 08.
    View PubMed
  151. AREDS2 Research Group, Al-Holou SN, Tucker WR, Agrón E, Clemons TE, Sperduto RD, Ferris FL 3rd, Chew EY. The Association of Statin Use with Cataract Progression and Cataract Surgery: The AREDS2 Report Number 8. Ophthalmology. 2016 Apr; 123(4):916-7. Epub 2015 Dec 11.
    View PubMed
  152. Sharma S, Toth CA, Daniel E, Grunwald JE, Maguire MG, Ying GS, Huang J, Martin DF, Jaffe GJ. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials Ophthalmology. 2016; 123(4):865-75.
  153. Raja H, Mercer RC, Bakri SJ. PRESUMED POSTERIOR UVEITIS RELATED TO EHRLICHIA EXPOSURE. Retin Cases Brief Rep. 2016 Spring; 10: (2)134-6.
    View PubMed
  154. Bakri SJ, Omar AF, Iezzi R, Kapoor KG. EVALUATION OF MULTIPLE DEXAMETHASONE INTRAVITREAL IMPLANTS IN PATIENTS WITH MACULAR EDEMA ASSOCIATED WITH RETINAL VEIN OCCLUSION. Retina. 2016 Mar; 36(3):552-7.
    View PubMed
  155. Daniel E, Shaffer J, Ying GS, Grunwald JE, Martin DF, Jaffe GJ, Maguire MG, Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group. Outcomes in Eyes with Retinal Angiomatous Proliferation in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT). Ophthalmology. 2016 Mar; 123(3):609-16. Epub 2015 Dec 08.
    View PubMed
  156. Wells JA, Glassman AR, Jampol LM, Aiello LP, Antoszyk AN, Baker CW, Bressler NM, Browning DJ, Connor CG, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW, Diabetic Retinopathy Clinical Research Network. Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema. JAMA Ophthalmol. 2016 Feb; 134(2):127-34.
    View PubMed
  157. Ying GS, Maguire MG, Daniel E, Grunwald JE, Ahmed O, Martin DF, CATT. Association between Antiplatelet or Anticoagulant Drugs and Retinal or Subretinal Hemorrhage in the Comparison of Age-Related Macular Degeneration Treatments Trials Ophthalmology. 2016.
  158. Bakri SJ. Eight questions with darius moshfeghi Ophthalmic Surgery Lasers and Imaging Retina. 2016; 47: (7)696, 694-5.
  159. Raja H, Starr MR, Bakri SJ. Ocular manifestations of tick-borne diseases. Surv Ophthalmol. 2016 Nov-Dec; 61(6):726-744. Epub 2016 Apr 07.
    View PubMed
  160. Heier JS, Bressler NM, Avery RL, Bakri SJ, Boyer DS, Brown DM, Dugel PU, Freund KB, Glassman AR, Kim JE, Martin DF, Pollack JS, Regillo CD, Rosenfeld PJ, Schachat AP, Wells JA 3rd, American Society of Retina Specialists Anti-VEGF for Diabetic Macular Edema Comparative Effectiveness Panel. Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical Practice. JAMA Ophthalmol. 2016 Jan; 134 (1):95-9
    View PubMed
  161. Bajric J, Bakri SJ. Outcomes of Patients Initially Treated with Intravitreal Bevacizumab for Central Retinal Vein Occlusion: Long-Term Follow-Up. Semin Ophthalmol. 2016; 31 (6):542-7 Epub 2015 Apr 30
    View PubMed
  162. Ying GS, Maguire MG, Daniel E, Ferris FL, Jaffe GJ, Grunwald JE, Toth CA, Huang J, Martin DF, CATT. Association of Baseline Characteristics and Early Vision Response with 2-Year Vision Outcomes in the Comparison of AMD Treatments Trials (CATT) Ophthalmology. 2015.
  163. Kim SJ, Schoenberger SD, Thorne JE, Ehlers JP, Yeh S, Bakri SJ. Topical Nonsteroidal Anti-inflammatory Drugs and Cataract Surgery: A Report by the American Academy of Ophthalmology. Ophthalmology. 2015 Nov; 122 (11):2159-68 Epub 2015 June 26
    View PubMed
  164. 33. AS, Ying GS, Toth CA, Maguire MG, Burns RE, Grunwald JE, Daniel E, Jaffe GJ, CATT. Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials Ophthalmology. 2015.
  165. Bakri SJ, Larson TA. The variable efficacy of intravitreal bevacizumab and triamcinolone acetonide for cystoid macular edema due to radiation retinopathy. Semin Ophthalmol. 2015 Jul; 30(4):276-80. Epub 2013 Nov 19.
    View PubMed
  166. Cuilla TA, Ying GS, Maguire MG, Martin DF, Jaffe GJ, Grunwald JE, Daniel E, Toth CA. Influence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials Ophthalmology. 2015; 122(6):1203-11.
  167. Hagstrom SA, Ying GS, Maguire MG, Martin DF, Gibson J, Lotery A, Chakravarthy U, IVAN Study Investigators. VEGFR2 Gene Polymorphisms and Response to Anti-Vascular Endothelial Growth Factor Therapy in Age-Related Macular Degeneration Ophthalmology. 2015.
  168. Dedania VS, Bakri SJ. SUSTAINED ELEVATION OF INTRAOCULAR PRESSURE AFTER INTRAVITREAL ANTI-VEGF AGENTS: What Is the Evidence? Retina. 2015 May; 35 (5):841-58
    View PubMed
  169. Yeh S, Kim SJ, Ho AC, Schoenberger SD, Bakri SJ, Ehlers JP, Thorne JE. Therapies for macular edema associated with central retinal vein occlusion: a report by the American Academy of Ophthalmology. Ophthalmology. 2015 Apr; 122 (4):769-78 Epub 2015 Jan 08
    View PubMed
  170. Dedania VS, Bakri SJ. Novel pharmacotherapies in diabetic retinopathy. Middle East Afr J Ophthalmol. 2015 Apr-Jun; 22 (2):164-73
    View PubMed
  171. Meredith TA, McCannel CA, Barr C, Doft BH, Peskin E, Maguire MG, Martin DF, Prenner JL. Postinjection endophthalmitis in the comparison of age-related macular degeneration treatments trials (CATT) Ophthalmology. 2015; 122(4):817-21.
  172. Grunwald JE, Pistilli M, Ying GS, Maguire MG, Daniel E, Martin DF. Growth of geographic atrophy in the comparison of age-related macular degeneration treatments trials Ophthalmology. 2015; 122(4):809-16.
  173. Dedania VS, Grob S, Zhang K, Bakri SJ. Pharmacogenomics of response to anti-VEGF therapy in exudative age-related macular degeneration. Retina. 2015 Mar; 35 (3):381-91
    View PubMed
  174. Altaweel MM, Daniel E, Martin DF, Mittra RA, Grunwald JE, Lai MM, Melamud A, Morse LS, Huang J, Ferris FL 3rd, Fine SL, Maguire MG. Outcomes of eyes with lesions composed of >50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Ophthalmology. 2015; 122(2):391-398.e5.
  175. Bakri SJ. Clinical trials: a need to better define the control group as current standard of care Ophthalmology. 2015; 122(2):391-398.e5.
  176. Altaweel MM, Daniel E, Martin DF, Mittra RA, Grunwald JE, Lai MM, Melamud A, Morse LS, Huang J, Ferris FL 3rd, Fine SL, Maguire MG, Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group, Comparison of Age-related Macular Degeneration Treatments Trials CATT Research Group. Outcomes of eyes with lesions composed of >50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT). Ophthalmology. 2015 Feb; 122(2):391-398.e5. Epub 2014 Oct 11.
    View PubMed
  177. Dedania VS, Bakri SJ. Current perspectives on ranibizumab. Clin Ophthalmol. 2015; 9:533-42 Epub 2015 Mar 20
    View PubMed
  178. Kapoor KG, Barkmeier AJ, Bakri SJ. Optical coherence tomography in retinal arterial occlusions: case series and review of the literature. Semin Ophthalmol. 2015 Jan; 30(1):74-9. Epub 2013 Sep 27.
    View PubMed
  179. Bakri SJ, Swanson JW. Asymptomatic peripheral retinal hemorrhages as a manifestation of interferon beta 1a retinopathy. Semin Ophthalmol. 2015 Jan; 30(1):56-7. Epub 2013 Aug 16.
    View PubMed
  180. Avery RL, Bakri SJ, Blumenkranz MS, Brucker AJ, Cunningham ET Jr, D'Amico DJ, Dugel PU, Flynn HW Jr, Freund KB, Haller JA, Jumper JM, Liebmann JM, McCannel CA, Mieler WF, Ta CN, Williams GA. Intravitreal injection technique and monitoring: updated guidelines of an expert panel. Retina. 2014 Dec; 34 Suppl 12:S1-S18.
    View PubMed
  181. Lee JY, Folgar FA, Maguire MG, Ying GS, Toth CA, Martin DF, Jaffe GJ. Outer retinal tubulation in the comparison of age-related macular degeneration treatments trials (CATT) Ophthalmology. 2014; 121(12):2423-31.
  182. Folgar FA, Jaffe GJ, Ying GS, Maguire MG, Toth CA, Comparison of Age-Related Macular Degeneration Treatments Trials Research Group. Comparison of optical coherence tomography assessments in the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2014 Oct; 121(10):1956-65. Epub 2014 May 15.
    View PubMed
  183. Bakri SJ, Boyer DS, Albini TA, Holekamp NM, Ferrone PJ, Bhagat R, Novakovic Z. Comparison of the tissue penetration and glide force of 22-gauge thin-wall needles for intravitreal implant administration. Ophthalmic Surg Lasers Imaging Retina. 2014 Sep-Oct; 45(5):430-5.
    View PubMed
  184. Gewaily DY, Grunwald JE, Pistilli M, Ying GS, Maguire MG, Daniel E, Ostroff CP, Fine SL. Delayed patchy choroidal filling in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Am J Ophthalmol. 2014; 158(3):525-31.
  185. Ying GS, Kim BJ, Maguire MG, Huang J, Daniel E, Jaffe GJ, Grunwald JE, Blinder KJ, Flaxel CJ, Rahhal F, Regillo C, Martin DF. Sustained visual acuity loss in the comparison of age-related macular degeneration treatments trials JAMA Ophthalmology. 2014; 132(8):915-21.
  186. Kim BJ, Ying GS, Huang J, Levy NE, Maguire MG, CATT Research Group. Sporadic visual acuity loss in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT). Am J Ophthalmol. 2014 Jul; 158(1):128-135.e10. Epub 2014 Apr 13.
    View PubMed
  187. Huynh N, Nicholson BP, Agrón E, Clemons TE, Bressler SB, Rosenfeld PJ, Chew EY. Visual acuity after cataract surgery in patients with age-related macular degeneration: age-related eye disease study 2 report number 5 Ophthalmology. 2014; 121(6):1229-36.
  188. Hagstrom SA, Ying GS, Pauer GJ, Huang J, Maguire MG, Martin DF. Endothelial PAS domain-containing protein 1 (EPAS1) gene polymorphisms and response to anti-VEGF therapy in the comparison of AMD treatments trials (CATT) Ophthalmology. 2014; 121(6):1229-36.
  189. Hagstrom SA, Ying GS, Pauer GJ, Sturgill-Short GM, Huang J, Maguire MG, Martin DF, Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group . VEGFA and VEGFR2 gene polymorphisms and response to anti-vascular endothelial growth factor therapy: comparison of age-related macular degeneration treatments trials (CATT). JAMA Ophthalmol. 2014 May; 132: (5)521-7.
    View PubMed
  190. Bakri SJ, Moshfeghi DM, Francom S, Rundle AC, Reshef DS, Lee PP, Schaeffer C, Rubio RG, Lai P. Intraocular pressure in eyes receiving monthly ranibizumab in 2 pivotal age-related macular degeneration clinical trials. Ophthalmology. 2014 May; 121 (5):1102-8 Epub 2014 Jan 06
    View PubMed
  191. Bonds DE, Harrington M, Worrall BB, Bertoni AG, Eaton CB, Hsia J, Robinson J, Clemons TE, Fine LJ, Chew EY. Effect of long-chain ?-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial JAMA Intern Med. 2014; 174(5):763-71.
  192. Bakri SJ, Alniemi ST. Fibrotic encapsulation of a dexamethasone intravitreal implant following vitrectomy and silicone oil for rhegmatogenous retinal detachment. Ophthalmic Surg Lasers Imaging Retina. 2014 May-Jun; 45 (3):243-5 Epub 2014 May 12
    View PubMed
  193. Daniel E, Toth CA, Grunwald JE, Jaffe GJ, Martin DF, Fine SL, Huang J, Ying GS, Hagstrom SA, Winter K, Maguire MG, CATT. Risk of scar in the comparison of age-related macular degeneration treatments trials Ophthalmology. 2014.
  194. Chew EY, Clemons TE, Sangiovanni JP, Danis RP, Ferris FL 3rd, Elman MJ, Antoszyk AN, Ruby AJ, Orth D, Bressler SB, Fish GE, Hubbard GB, Klein ML, Chandra SR, Blodi BA, Domalpally A, Friberg T, Wong WT, Rosenfeld PJ, Agrón E, Toth CA, Bernstein PS, Sperduto RD. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3 JAMA Ophthalmology. 2014; 132(2):142-9.
  195. Grunwald JE, Daniel E, Huang J, Ying GS, Maguire MG, Toth CA, Jaffe GJ, Fine SL, Blodi B, Klein ML, Martin AA, Hagstrom SA, Martin DF. Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials Ophthalmology. 2014; 121(1):150-61.
  196. Bakri SJ, Luqman A, Pathik B, Chandrasekaran K. Is carotid ultrasound necessary in the evaluation of the asymptomatic Hollenhorst plaque? Ophthalmology. 2013 Dec; 120 (12):2747-2748.e1
    View PubMed
  197. Maguire MG, Daniel E, Shah AR, Grunwald JE, Hagstrom SA, Avery RL, Huang J, Martin RW, Roth DB, Castellarin AA, Bakri SJ, Fine SL, Martin DF, Comparison of Age-Related Macular Degeneration Treatments Trials (CATT Research Group). Incidence of choroidal neovascularization in the fellow eye in the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2013 Oct; 120(10):2035-41. Epub 2013 May 22
    View PubMed
  198. Domalpally A, Danis RP, Chew EY, Clemons TE, Reed S, Sangiovanni JP, Ferris FL 3rd, AREDS2. Evaluation of optimized digital fundus reflex photographs for lens opacities in the age-related eye disease study 2: AREDS2 report 7 Invest Ophthalmol Vis Sci. 2013.
  199. Jaffe GJ, Martin DF, Toth CA, Daniel E, Maguire MG, Ying GS, Grunwald JE, Huang J, Comparison of Age-related Macular Degeneration Treatments Trials Research Group. Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2013 Sep; 120(9):1860-70. Epub 2013 May 01.
    View PubMed
  200. Bakri SJ, Luqman A, Pathik B, Chandrasekaran K. Is carotid ultrasound necessary in the clinical evaluation of the asymptomatic Hollenhorst plaque? (An American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2013 Sep; 111:17-23
    View PubMed
  201. Pershing S, Bakri SJ, Moshfeghi DM. Ocular hypertension and intraocular pressure asymmetry after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmic Surg Lasers Imaging Retina. 2013 Sep-Oct; 44(5):460-4.
    View PubMed
  202. Danis RP, Domalpally A, Chew EY, Clemons TE, Armstrong J, SanGiovanni JP, Ferris FL 3rd, AREDS2 Study Group. Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2). Invest Ophthalmol Vis Sci. 2013 Jul 08; 54(7):4548-54.
    View PubMed
  203. Chew EY, SanGiovanni JP, Ferris FL, Wong WT, Agron E, Clemons TE, Sperduto R, Danis R, Chandra SR, Blodi BA, Domalpally A, Elman MJ, Antoszyk AN, Ruby AJ, Orth D, Bressler SB, Fish GE, Hubbard GB, Klein ML, Friberg TR, Rosenfeld PJ, Toth CA, Bernstein P. Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4 JAMA Ophthalmol. 2013; 131(7):843-50.
  204. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial JAMA. 2013; 309(19):2005-15.
  205. Kapoor KG, Bakri SJ. Intravitreal anti-vascular endothelial growth factor therapy for choroidal neovascularization due to Sorsby macular dystrophy. J Ocul Pharmacol Ther. 2013 May; 29 (4):444-7 Epub 2013 Apr 12
    View PubMed
  206. Hagstrom SA, Ying GS, Pauer GJ, Sturgill-Short GM, Huang J, Callanan DG, Kim IK, Klein ML, Maguire MG, Martin DF, Comparison of AMD Treatments Trials Research Group. Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT). Ophthalmology. 2013 Mar; 120: (3)593-9.
    View PubMed
  207. Bakri SJ, Alniemi ST, Chan RV. Experiences of vitreoretinal surgery fellows in the United States. Retina. 2013 Feb; 33(2):392-6.
    View PubMed
  208. Ying GS, Huang J, Maguire MG, Jaffe GJ, Grunwald JE, Toth C, Daniel E, Klein M, Pieramici D, Wells J, Martin DF. Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration Ophthalmology. 2013; 120(1):122-9.
  209. Ying GS, Huang J, Maguire MG, Jaffe GJ, Grunwald JE, Toth C, Daniel E, Klein M, Pieramici D, Wells J, Martin DF, Comparison of Age-related Macular Degeneration Treatments Trials Research Group. Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration. Ophthalmology. 2013 Jan; 120(1):122-9. Epub 2012 Oct 06.
    View PubMed
  210. Bakri SJ, Omar AF. Delayed scleral buckle infection due to Alternaria species. Semin Ophthalmol. 2013 Jan; 28(1):9-10.
    View PubMed
  211. Green-Simms AE, Fechtel BM, Agarwal Z, Bakri SJ. Visual and anatomical outcomes of anti-vascular endothelial growth factor therapy in exudative age-related macular degeneration and vitreomacular interface disease: Vitreomacular adhesion and epiretinal membrane. Retina. 2013; 33(7):1359-64.
  212. DeCroos FC, Toth CA, Stinnett SS, Heydary CS, Burns R, Jaffe GJ. Optical coherence tomography grading reproducibility during the Comparison of Age-related Macular Degeneration Treatments Trials Ophthalmology. 2012; 119(12):2549-57.
  213. Chew EY, Clemons T, SanGiovanni JP, Danis R, Domalpally A, McBee W, Sperduto R, Ferris FL. The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1) Ophthalmology. 2012; 119(11):2282-9.
  214. Bakri SJ, Omar AF. Evolution of vitreomacular traction following the use of the dexamethasone intravitreal implant (Ozurdex) in the treatment of macular edema secondary to central retinal vein occlusion. J Ocul Pharmacol Ther. 2012 Oct; 28(5):547-9. Epub 2012 Apr 26.
    View PubMed
  215. Kapoor KG, Bakri SJ. Air bubbles emanating from the vitrector probe port during vitrectomy. Ophthalmic Surg Lasers Imaging. 2012 Sep-Oct; 43(5):439-40. Epub 2012 Jul 19.
    View PubMed
  216. Grunwald JE, Daniel E, Ying GS, Pistilli M, Maguire MG, Alexander J, Whittock-Martin R, Parker CR, Sepielli K, Blodi BA, Martin DF. Photographic assessment of baseline fundus morphologic features in the Comparison of Age-Related Macular Degeneration Treatments Trials Ophthalmology. 2012; 119(8):1634-41.
  217. Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group, Martin DF, Maguire MG, Fine SL, Ying GS, Jaffe GJ, Grunwald JE, Toth C, Redford M, Ferris FL 3rd. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology. 2012 Jul; 119(7):1388-98. Epub 2012 May 01.
    View PubMed
  218. McCannel CA, Olson EJ, Donaldson MJ, Bakri SJ, Pulido JS, Mueller D. Snoring is associated with unexpected patient head movement during monitored anesthesia care vitreoretinal surgery. Retina. 2012 Jul; 32(7):1324-7.
    View PubMed
  219. Abu-Yaghi NE, Bakri SJ. The use of antivascular endothelial growth factor agents in the perioperative period in diabetic vitrectomy. Middle East Afr J Ophthalmol. 2012 Jan; 19(1):83-7.
    View PubMed
  220. Abu-Yaghi NE, Hartono SP, Hodge DO, Pulido JS, Bakri SJ. White dot syndromes: a 20-year study of incidence, clinical features, and outcomes. Ocul Immunol Inflamm. 2011 Dec; 19 (6):426-30
    View PubMed
  221. Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jiao J, Li XY, Whitcup SM, Li J, Ozurdex GENEVA Study Group. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology. 2011 Dec; 118 (12):2453-60 Epub 2011 July 20
    View PubMed
  222. Shultz RW, Bakri SJ. Treatment for submacular hemorrhage associated with neovascular age-related macular degeneration. Semin Ophthalmol. 2011 Nov; 26(6):361-71.
    View PubMed
  223. Engman SJ, Edwards AO, Bakri SJ. Administration of repeat intravitreal anti-VEGF drugs by retina specialists in an injection-only clinic for patients with exudative AMD: patient acceptance and safety. Semin Ophthalmol. 2011 Nov; 26(6):380-6.
    View PubMed
  224. Bakri SJ, Cousins SW, Gower EW, Kaiser PK, Martin DF, Rich WL III. CATT, Hopkins analysis add fervor to ranibizumab vs. bevacizumab debate. Ocul Surg News. 2011 Aug 10; 29(15):1-12.
  225. Dosunmu EO, Bakri SJ. Mimickers of age-related macular degeneration. Semin Ophthalmol. 2011 May; 26(3):209-15.
    View PubMed
  226. Green-Simms AE, Bakri SJ. Vitreomacular traction and age-related macular degeneration. Semin Ophthalmol. 2011 May; 26(3):137-8.
    View PubMed
  227. Couch SM, Bakri SJ. Review of combination therapies for neovascular age-related macular degeneration. Semin Ophthalmol. 2011 May; 26(3):114-20.
    View PubMed
  228. Olson JH, Erie JC, Bakri SJ. Nutritional supplementation and age-related macular degeneration. Semin Ophthalmol. 2011 May; 26 (3):131-6
    View PubMed
  229. Doshi RR, Bakri SJ, Fung AE. Intravitreal injection technique. Semin Ophthalmol. 2011 May; 26(3):104-13.
    View PubMed
  230. Green-Simms AE, Ekdawi NS, Bakri SJ. Survey of intravitreal injection techniques among retinal specialists in the United States. Am J Ophthalmol. 2011 Feb; 151(2):329-32. Epub 2010 Dec 18.
    View PubMed
  231. Bressler SB, Bakri SJ, Friedman SM, Michael S. Evaluating and integrating new evidence in the treatment of diabetic macular edema. Retina Today. 2011 Jan(Suppl):20.
  232. Roe RH, Boyer DS, Spirn MJ, Bakri SJ. Diagnostic and therapeutic challenges. Retina. 2010 Jul-Aug; 30 (7):1155-8
    View PubMed
  233. Campochiaro PA Heier JS Feiner L Gray S Saroj N Rundle AC Murahashi WY Rubio RG, BRAVO Investigators. Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology. 2010 Jun; 117(6):1102-1112.
  234. Brown DM Campochiaro PA Singh RP Li Z Gray S Saroj N Rundle AC Rubio RG Murahashi WY, CRUISE Investigators. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology. 2010 Jun; 117(6):1124-1133.
  235. Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM, OZURDEX GENEVA Study Group. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology. 2010 Jun; 117 (6):1134-1146.e3 Epub 2010 Apr 24
    View PubMed
  236. Bakri SJ, Sears JE, Procop GW, Shrestha R, Gordon SM. Excellent visual outcome following Aspergillus flavus endogenous endophthalmitis-farmer's lung disease. Int Ophthalmol. 2010 Feb; 30 (1):99-101 Epub 2009 Jan 09
    View PubMed
  237. Bakri SJ, Risco M, Edwards AO, Pulido JS. Bilateral simultaneous intravitreal injections in the office setting. Am J Ophthalmol. 2009 Jul; 148(1):66-9.e1. Epub 2009 Apr 29.
    View PubMed
  238. Bakri SJ, Edwards AO, Couch SM. Noninfectious endophthalmitis occurring after intravitreal triesence injection. Retin Cases Brief Rep. 2009 Summer; 3(3):316-8.
    View PubMed
  239. Silva PS, Singh RJ, Bakri SJ, Lising RS, Santiago DE, Uy HS. Vitreous concentration of triamcinolone acetonide after a single transseptal depot injection. Ocul Immunol Inflamm. 2009 May-Jun; 17(3):216-20.
    View PubMed
  240. Diago T, McCannel CA, Bakri SJ, Pulido JS, Edwards AO, Pach JM. Infectious endophthalmitis after intravitreal injection of antiangiogenic agents. Retina. 2009 May; 29 (5):601-5
    View PubMed
  241. Bakri SJ, Couch SM, McCannel CA, Edwards AO. Same-day triple therapy with photodynamic therapy, intravitreal dexamethasone, and bevacizumab in wet age-related macular degeneration. Retina. 2009 May; 29(5):573-8.
    View PubMed
  242. Itty S, Bakri SJ, Pulido JS, Herman DC, Faia LJ, Tufty GT, Bennett SR, Falk NS. Initial results of QuantiFERON-TB Gold testing in patients with uveitis. Eye (Lond). 2009 Apr; 23(4):904-9. Epub 2008 May 02.
    View PubMed
  243. Amselem L, Pulido JS, Gunduz K, Bakri SJ, Diaz-Llopis M, Dolan JW, Morgan K, De Souza S, Link T, Rosvold J. Changes in fundus autofluorescence of choroidal melanomas following treatment. Eye (Lond). 2009 Feb; 23 (2):428-34 Epub 2007 Oct 19
    View PubMed
  244. Fung AE, Palanki R, Bakri SJ, Depperschmidt E, Gibson A. Applying the CONSORT and STROBE statements to evaluate the reporting quality of neovascular age-related macular degeneration studies. Ophthalmology. 2009 Feb; 116(2):286-96. Epub 2008 Dec 16.
    View PubMed
  245. Bakri SJ. Special considerations in the treatment of neovascular age-related macular degeneration Key Opinion Leader Corner Retina Times. 2009; 23(26).
  246. Bakri SJ. Same-day triple therapy for wet AMD: Reduced fluence PDT, intravitreal bevacizumab, and dexamethasone. Retina Today. 2009 Jan.
  247. Couch SM, Bakri SJ. Intravitreal triamcinolone for intraocular inflammation and associated macular edema. Clin Ophthalmol. 2009; 3:41-7 Epub 2009 June 02
    View PubMed
  248. Bakri SJ, Pulido JS, McCannel CA, Hodge DO, Diehl N, Hillemeier J. Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab. Eye (Lond). 2009 Jan; 23 (1):181-5 Epub 2007 Aug 10
    View PubMed
  249. Couch SM, Bakri SJ. Use of triamcinolone during vitrectomy surgery to visualize membranes and vitreous. Clin Ophthalmol. 2008 Dec; 2 (4):891-6
    View PubMed
  250. Ahuja Y, Couch SM, Razonable RR, Bakri SJ. Infectious Retinitis: a review. Retinal Physician. 2008 Nov-Dec:17-25.
  251. Hardwig PW, Pulido JS, Bakri SJ. The safety of intraocular methotrexate in silicone-filled eyes. Retina. 2008 Oct; 28(8):1082-6.
    View PubMed
  252. Gunduz K, Bakri SJ. Intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion. Eye (Lond). 2008 Sep; 22(9):1168-71. Epub 2008 Mar 14.
    View PubMed
  253. Hubbard LD, Danis RP, Neider MW, Thayer DW, Wabers HD, White JK, Pugliese AJ, Pugliese MF, Age-Related Eye Disease 2 Research Group. Brightness, contrast, and color balance of digital versus film retinal images in the age-related eye disease study 2. Invest Ophthalmol Vis Sci. 2008 Aug; 49 (8):3269-82 Epub 2008 Apr 17
    View PubMed
  254. Bakri SJ, Ekdawi NS. Intravitreal silicone oil droplets after intravitreal drug injections. Retina. 2008 Jul-Aug; 28 (7):996-1001
    View PubMed
  255. Bakri SJ, McCannel CA, Edwards AO, Moshfeghi DM. Persisent ocular hypertension following intravitreal ranibizumab. Graefes Arch Clin Exp Ophthalmol. 2008 Jul; 246 (7):955-8 Epub 2008 Apr 19
    View PubMed
  256. Bakri SJ, Ekdawi NS. Intravitreal triamcinolone and bevacizumab combination therapy for refractory choroidal neovascularization with retinal angiomatous proliferation. Eye (Lond) 2008 Jul; 22 (7):978-80 Epub 2007 Nov 23
    View PubMed
  257. Bakri SJ, Larson TA, Edwards AO. Intraocular inflammation following intravitreal injection of bevacizumab. Graefes Arch Clin Exp Ophthalmol. 2008 May; 246 (5):779-81 Epub 2008 Jan 17
    View PubMed
  258. Eid AJ, Bakri SJ, Kijpittayarit S, Razonable RR. Clinical features and outcomes of cytomegalovirus retinitis after transplantation. Transpl Infect Dis. 2008 Feb; 10 (1):13-8 Epub 2007 May 19
    View PubMed
  259. Itty S, Pulido JS, Bakri SJ, Baratz KH, Matteson EL, Hodge DO. Anti-cyclic citrullinated peptide, rheumatoid factor, and ocular symptoms typical of rheumatoid arthritis. Trans Am Ophthalmol Soc. 2008; 106:75-81; discussion 81-3
    View PubMed
  260. Bakri SJ, Pulido JS, Mukherjee P, Marler RJ, Mukhopadhyay D. Absence of histologic retinal toxicity of intravitreal nanogold in a rabbit model. Retina. 2008 Jan; 28(1):147-9.
    View PubMed
  261. Collet L, Larson TA, Bakri SJ. Bevacizumab for ophthalmic disease. US Ophthalmic Review. 2007 Dec.
  262. Bakri SJ, Snyder MR, Reid JM, Pulido JS, Ezzat MK, Singh RJ. Pharmacokinetics of intravitreal ranibizumab (Lucentis). Ophthalmology. 2007 Dec; 114 (12):2179-82
    View PubMed
  263. Solano JM, Bakri SJ, Pulido JS. Regression of radiation-induced macular edema after systemic bevacizumab. Can J Ophthalmol. 2007 Oct; 42: (5)748-9.
    View PubMed
  264. Pulido JS, Bakri SJ, Valyi-Nagy T, Shukla D. Rituximab penetrates full-thickness retina in contrast to tissue plasminogen activator control. Retina. 2007 Oct; 27(8):1071-3.
    View PubMed
  265. Gunduz K, Bakri SJ. Management of proliferative diabetic retinopathy. Compr Ophthalmol Update. 2007 Sep-Oct; 8(5):245-56.
    View PubMed
  266. Amselem L, Montero J, Diaz-Llopis M, Pulido JS, Bakri SJ, Palomares P, Garcia-Delpech S. Intravitreal bevacizumab (Avastin) injection in ocular ischemic syndrome. Am J Ophthalmol. 2007 Jul; 144(1):122-4.
    View PubMed
  267. Gunduz K, Pulido JS, Bakri SJ, Petit-Fond E. Fundus autofluorescence in choroidal melanocytic lesions. Retina. 2007 Jul-Aug; 27 (6):681-7
    View PubMed
  268. Michels S, Prager F, Bakri SJ, Wachtlin J. Bevacizumab for ophthalmic diseases. Expert Review of Ophthalmology. 2007 Jun; 2(3):369-78.
  269. Pulido JS, Pulido CM, Bakri SJ, McCannel CA, Cameron JD. The use of 31-gauge needles and syringes for intraocular injections. Eye (Lond). 2007 Jun; 21(6):829-30. Epub 2006 Jul 14.
    View PubMed
  270. Bakri K, Pulido JS, Bakri SJ. Autofluorescence of choroidal melanomas. Retin Cases Brief Rep. 2007 Summer; 1(3):117-9.
    View PubMed
  271. Bakri SJ, Snyder MR, Reid JM, Pulido JS, Singh RJ. Pharmacokinetics of intravitreal bevacizumab (Avastin). Ophthalmology. 2007 May; 114 (5):855-9
    View PubMed
  272. Bakri SJ, Sears JE, Lewis H. Management of macular hole and submacular hemorrhage in the same eye. Graefes Arch Clin Exp Ophthalmol. 2007 Apr; 245 (4):609-11 Epub 2006 July 27
    View PubMed
  273. Bakri SJ, Sears JE, Lewis H. Management of macular hole during pneumatic displacement of subretinal hemorrhage with subretinal t-PA Graefes Arch Clin Exp Ophthalmol. 2007; 245(4):609-11.
  274. Bakri SJ, Kitzmann AS. Retinal pigment epithelial tear after intravitreal ranibizumab. Am J Ophthalmol. 2007 Mar; 143(3):505-7. Epub 2006 Dec 28.
    View PubMed
  275. Gunduz K, Pulido JS, Bakri SJ, Amselem L, Petit-Fond E, Link T. Fundus autofluorescence of choroidal melanocytic lesions and the effect of treatment. Trans Am Ophthalmol Soc. 2007; 105:172-8; discussion 178-9
    View PubMed
  276. Bakri SJ, Singh AD, Lowder CY, Chalita MR, Li Y, Izatt JA, Rollins AM, Huang D. Imaging of iris lesions with high-speed optical coherence tomography. Ophthalmic Surg Lasers Imaging. 2007 Jan-Feb; 38(1):27-34.
    View PubMed
  277. Bakri SJ, Sculley L, Singh AD. Imaging techniques for uveal melanoma. Int Ophthalmol Clin. 2006 Winter; 46(1):1-13.
    View PubMed
  278. Galor A, Perry JD, Ratliff N, Kaiser PK, Bakri SJ, Lee MS. Failure of imaging to detect optic nerve avulsion: an explanation based on histopathology. Eye. 2006 Aug; 20(8):965-7.
  279. Bakri SJ, Nickel J, Yoganathan P, Beer PM. Photodynamic therapy for choroidal neovascularization associated with submacular hemorrhage in age-related macular degeneration. Ophthalmic Surg Lasers Imaging. 2006 Jul-Aug; 37 (4):278-83
    View PubMed
  280. Bakri SJ, Cameron JD, McCannel CA, Pulido JS, Marler RJ. Absence of histologic retinal toxicity of intravitreal bevacizumab in a rabbit model. Am J Ophthalmol. 2006 Jul; 142(1):162-4.
    View PubMed
  281. Bakri SJ, Snyder MR, Pulido JS, McCannel CA, Weiss WT, Singh RJ. Six-month stability of bevacizumab (Avastin) binding to vascular endothelial growth factor after withdrawal into a syringe and refrigeration or freezing. Retina. 2006 May-Jun; 26 (5):519-22
    View PubMed
  282. Bakri SJ, Kaiser PK. Anecortave acetate. Expert Opin Investig Drugs. 2006 Feb; 15(2):163-9.
    View PubMed
  283. Costello P, Bakri SJ, Beer PM, Singh RJ, Falk NS, Peters GB, Melendez JA. Vitreous penetration of topical moxifloxacin and gatifloxacin in humans. Retina. 2006 Feb; 26(2):191-5.
    View PubMed
  284. Bakri SJ, Sears JE, Singh AD. Transient closure of a retinal capillary hemangioma with verteporfin photodynamic therapy. Retina. 2005 Dec; 25(8):1103-4.
    View PubMed
  285. Bakri SJ, Beer PM. Photodynamic therapy for maculopathy due to radiation retinopathy. Eye. 2005 Jul; 19(7):795-9.
    View PubMed
  286. Bakri SJ, Beer PM. Verteporfin photodynamic therapy for macular edema secondary to radiation retinopathy. Eye. 2005 Jun; 19(6):686-8.
  287. Bakri SJ, Shah A, Falk NS, Beer PM. Intravitreal preservative-free triamcinolone acetonide for the treatment of macular oedema. Eye. 2005 Jun; 19(6):686-8.
    View PubMed
  288. Bakri SJ, Peters GB 3rd. Sympathetic ophthalmia after a hyphema due to nonpenetrating trauma. Ocul Immunol Inflamm. 2005 Feb; 13(1):85-6.
    View PubMed
  289. Bakri SJ, Kaiser PK. Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema. Am J Ophthalmol. 2005 Feb; 139(2):290-4.
    View PubMed
  290. Bakri SJ, Beer PM. Intravitreal triamcinolone acetonide for the treatment of macular diseases. Comprehensive Ophthalmology Update. 2005(6).
  291. Bakri SJ, Peters GB. Sympathetic ophthalmia secondary to traumatic hyphema. Ocul Immunol Inflamm. 2005; 12:85-6.
  292. Moshfeghi DM, Kaiser PK, Bakri SJ, Kaiser RS, Maturi RK, Sears JE, Scott IU, Belmont J, Beer PM, Quiroz-Mercado H, Mieler WF. Presumed sterile endophthalmitis following intravitreal triamcinolone acetonide injection. Ophthalmic Surgery, Lasers & Imaging. 2005 Jan-Feb; 36(1):24-9.
    View PubMed
  293. Bakri SJ, Beer PM. Intravitreal triamcinolone injection for diabetic macular edema: a clinical and fluorescein angiographic case series. Can J Ophthalmol. 2004 Dec; 39(7):755-60.
    View PubMed
  294. Bakri SJ, Kaiser PK. Age-related macular degeneration. Review of Ophthalmology Supplement. 2004 Sept.
  295. Bakri SJ, Shah A, Falk NS, Beer PM. Preservative-free intravitreal triamcinolone for macular edema. Eye. 2004 Aug 27.
  296. Bakri SJ, Kaiser PK. Intravitreal steroid injection for macular edema: is it ready for prime time? Retinal Physician. 2004 Aug; 40-5.
  297. Bakri SJ, Beer PM. Vitreoretinal surgery for optic pit associated serous macular detachment: a discussion of two cases. Int Ophthalmol. 2004 May; 25(3):143-6.
    View PubMed
  298. Bakri SJ, Kaiser PK. Verteporfin ocular photodynamic therapy. Expert Opin Pharmacother. 2004 Jan; 5(1):195-203.
    View PubMed
  299. Bakri SJ, Beer PM. Choroidal neovascularization after radial optic neurotomy for central retinal vein occlusion. Retina. 2004; 24(4):610-1.
    View PubMed
  300. Bakri SJ, Kaiser PK. Ocular manifestations of West Nile Virus. Curr Opin Ophthalmol. 2004; 15(6):537-40.
    View PubMed
  301. Moshfeghi DM, Kaiser PK, Scott IU, Sears JE, Benz M, Sinesterra JP, Kaiser RS, Bakri SJ, Maturi RK, Belmont J, Beer PM, Murray TG, Quiroz-Mercado H, Mieler WF. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol. 2003 Nov; 136(5):791-6.
    View PubMed
  302. Bakri SJ, Beer PM. Photodynamic therapy with verteporfin for classic choroidal neovascularization secondary to focal laser photocoagulation for radiation retinopathy. Ophthalmic Surg Lasers Imaging. 2003 Nov-Dec; 34(6):475-7.
    View PubMed
  303. Bakri SJ, Beer PM. The effect of intravitreal triamcinolone acetonide on intraocular pressure. Ophthalmic Surg Lasers Imaging. 2003 Sep-Oct; 34(5):386-90.
    View PubMed
  304. Bakri SJ, Krohel GB, Peters GB, Farber MG. Spermatic cord leiomyosarcoma metastatic to the orbit. Am J Ophthalmol. 2003 Jul; 136(1):213-5.
    View PubMed
  305. Beer PM, Bakri SJ, Singh RJ, Liu W, Peters GB 3rd, Miller M. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology. 2003 Apr; 110(4):681-6.
    View PubMed
  306. Bakri SJ, Carlson JA, Meyer DR. Recurrent solitary reticulohistiocytoma of the eyelid. Ophthal Plast Reconstr Surg. 2003 Mar; 19(2):162-4.
    View PubMed
  307. Abel AD, Carlson JA, Bakri SJ, Meyer DR. Sclerosing lipogranuloma of the orbit after periocular steroid injection. Ophthalmology. 2003; 110(9):1841-5.
    View PubMed
  308. Peters GB 3rd, Bakri SJ, Krohel GB. Cause and prognosis of nontraumatic sixth nerve palsies in young adults. Ophthalmology. 2002 Oct; 109(10):1925-8.
    View PubMed
  309. Bakri SJ, Carney AS, Robinson K, Jones NS, Downes RN. Quality of life outcomes following dacryocystorhinostomy: external and endonasal laser techniques compared. Orbit. 1999 Jun; 18(2):83-88.
    View PubMed
  310. Bakri SJ, Siker D, Masaryk T, Luciano MG, Traboulsi EI. Moyamoya disease, ocular malformations and midline cranial defects. Am J Ophthalmol. 1999; 127(3):356-7.
    View PubMed
  311. Bakri SJ, Carney AS, Downes RN, Jones NS. Endonasal laser-assisted dacryocystorhinostomy. Hosp Med. 1998 Mar; 59(3):210-5.
    View PubMed
PST-20223420